I don't think the Q3 access is actually sales.... I think it is giving the product to marketing...... " early patient experience " has marketting written all over it.
Botanix News, page-10
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $672.4M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 39.0¢ | 37.0¢ | $1.232M | 3.263M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 21 | 413183 | 37.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.0¢ | 50000 | 1 |
View Market Depth
| Last trade - 16.10pm 09/10/2024 (20 minute delay) ? |
| BOT (ASX) Chart |